Standardized Application of Flow Cytometry Antibodies in In Vitro Diagnostics and Quality Control

The Role of Flow Cytometry Antibodies in In Vitro Diagnostics

In the field of in vitro diagnostics, flow cytometry antibodies are widely used in immunophenotyping, cell function assessment, and detection of related markers. As part of the diagnostic reagent system, the quality stability, specificity, and batch-to-batch comparability of flow cytometry antibodies directly affect the reliability and reproducibility of test results. During the design, production, and application of related products, it is generally necessary to comply with the quality management system requirements for in vitro diagnostic reagents and to complete performance confirmation in accordance with standard operating procedures.

Performance Verification and Quality Control Indicators

Before incorporating flow cytometry antibodies into a testing process, verification may be conducted around general performance indicators such as specificity, repeatability, sensitivity, and linear range. During verification, representative positive and negative samples should be used, combined with known reference materials or control cells, to observe staining patterns and fluorescence intensity distribution. Commonly used quality control methods include:

Establishing control cells or reference samples to regularly monitor staining stability.

Recording the receipt inspection status and storage temperature of each batch of flow cytometry antibodies.

Evaluating staining consistency between different batches through parallel comparison.

Performing daily calibration of the instrument's optical path and voltage to reduce systematic errors.

Stability During Storage, Transportation, and Use

The activity of flow cytometry antibodies may be affected by factors such as temperature, light exposure, and mechanical vibration. After receipt, they should be stored protected from light at the temperature recommended in the product instructions, avoiding repeated freeze-thaw cycles. For diluted working solutions, even greater attention should be paid to shelf life and storage conditions. If fixation and permeabilization reagents are used in the experiment, the compatibility of the flow cytometry antibodies with this procedure should also be confirmed to avoid signal reduction caused by epitope disruption or fluorochrome quenching. Maintaining clear reagent usage records helps enable rapid traceability when deviations occur.

Compliant Expression and Boundaries of Industry Promotion

In in vitro diagnostics and scientific research service scenarios, introductions related to flow cytometry antibodies should be based on objective, verifiable information, avoiding absolute statements or expressions implying therapeutic claims. For product performance, neutral descriptions such as common specifications, general requirements, and recommended verification should be used, and users should be reminded to optimize according to their own sample types and instrument conditions. Through standardized technical materials and transparent quality control information, users can be helped to more reasonably select and apply flow cytometry antibodies, jointly safeguarding the credibility of test results and industry order.